Shandong Jincheng Pharmaceutical Group Co., Ltd. (300233) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Jincheng Pharmaceutical Group Co., Ltd.

Why is Shandong Jincheng Pharmaceutical Group Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.03% and Operating profit at 18.21% over the last 5 years

With a fall in Net Sales of -9.18%, the company declared Very Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 279.64 MM
ROCE(HY) Lowest at 2.1%
CASH AND EQV(HY) Lowest at CNY 1,495.24 MM

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 13.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -24.03% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shandong Jincheng Pharmaceutical Group Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Jincheng Pharmaceutical Group Co., Ltd.

-23.65%

-0.21

50.24%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.03%

EBIT Growth (5y)

18.21%

EBIT to Interest (avg)

10.44

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.75

Tax Ratio

23.63%

Dividend Payout Ratio

77.10%

Pledged Shares

Institutional Holding

ROCE (avg)

7.19%

ROE (avg)

5.55%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.96

EV to EBIT

49.63

EV to EBITDA

15.31

EV to Capital Employed

2.02

EV to Sales

2.40

PEG Ratio

Dividend Yield

2.04%

ROCE (Latest)

4.07%

ROE (Latest)

3.09%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.73% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -7.05 %

-38What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 279.64 MM

ROCE(HY)

Lowest at 2.1%

CASH AND EQV(HY)

Lowest at CNY 1,495.24 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.25 times

NET SALES(Q)

Lowest at CNY 571.78 MM

OPERATING PROFIT(Q)

Lowest at CNY -14.06 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -2.46 %

PRE-TAX PROFIT(Q)

Lowest at CNY -8.88 MM

NET PROFIT(Q)

Lowest at CNY -11.84 MM

EPS(Q)

Lowest at CNY -0.03

Here's what is working for Shandong Jincheng Pharmaceutical Group Co., Ltd.

Debt-Equity Ratio

Lowest at -7.05 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -4.73% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Jincheng Pharmaceutical Group Co., Ltd.

Net Sales

At CNY 571.78 MM has Fallen at -22.66%

over average net sales of the previous four periods of CNY 739.27 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -8.88 MM has Fallen at -121.59%

over average net sales of the previous four periods of CNY 41.12 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -11.84 MM has Fallen at -143.06%

over average net sales of the previous four periods of CNY 27.5 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 279.64 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 571.78 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY -14.06 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -2.46 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -8.88 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -11.84 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.03

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Cash and Eqv

Lowest at CNY 1,495.24 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 3.25 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio